JPRN-UMIN000008620已完成未知
The impact of DPP-4 inhibitor on daily glucose profile and coronary plaque character in impaired glucose tolerance patients with coronary artery disease - the impact of Vildagliptin On daily Glucose profile and coronary plaqUE character in impaired glucose tolerance patients with coronary artery disease:VOGUE-KOBE
Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine0 个研究点目标入组 24 人开始时间: 2012年8月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
Vildagliptin could reduce the MAGE at 6 months and may be associated with the decreased lipid arc and increased minimum FCT of the coronary plaques in CAD patients with IGT as compared with the control group. These findings may represent its potential stabilization effect on coronary plaques, which are characteristic in this patient subset.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients meeting one of the following conditions will be excluded: 1)under treatment of diabetes, or type 1 diabetes 2)severe liver dysfunction 3)severe renal dysfunction 4)severe heart failure) (NYHA/New York Heart Association stage III or severer) 5)Malignancies or other diseases with poor prognosis 6) pregnant, lactating, and possibly pregnant women and those planning to become pregnant 7) past medical history of hypersensitivity to investigational drugs 8) judged as ineligible by clinical investigators
研究者
相似试验
已完成
4 期
Effect of alogliptin , a DPP-4 inhibitor, on markers of lipid metabolism in type 2 diabetic patientsJPRN-UMIN000011470ara Hospital Kinki University Faculty of Medicine50
已完成
不适用
DIrect Effect of DPP-4 inhibitor on HbA1c levels and Renal DysfunctioType 2 diabetesJPRN-UMIN000012068Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University120
已完成
不适用
The impact of DPP-4 inhibitor on daily glucose profile and coronary plaque character in diabetic patients with coronary artery diseasepatients with coronary artery disease and type 2 diabetesJPRN-UMIN000008344Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine44
已完成
不适用
The efficacy of DPP-4 inhibitors and alpha glucosidase inhibitors for type 2diabetesPatients with type 2 diabetesJPRN-UMIN000011788ational Center for Global Health and Medicine15
撤回
1 期
The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder PatientsMajor Depressive DisorderNCT04410341Sadat City University100